The authors concluded that IR was apparent not in terms of surpassing of any predefined cut-off point, based on selected surrogate IR indices, but as a decreased insulin sensitivity, determined by the rate of glucose infusion during the clamp, in comparison to BMI-matched non-PCOS peers. The gene discussed is INS; the disease is polycystic ovary syndrome.